Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,043,000 | 2,853,000 | 416,000 | 1,944,000 | 1,786,000 |
| Marketable Securities | 19,434,000 | 9,837,000 | 22,316,000 | 29,125,000 | 10,437,000 |
| Receivables | 11,463,000 | 11,566,000 | 10,952,000 | 11,479,000 | 7,913,000 |
| Inventories | 10,851,000 | 10,189,000 | 8,981,000 | 9,059,000 | 8,020,000 |
| Income taxes - deferred | N/A | N/A | N/A | 4,266,000 | 3,264,000 |
| Other current assets | 7,567,000 | 8,888,000 | 8,594,000 | 3,820,000 | 3,647,000 |
| TOTAL | $50,358,000 | $43,333,000 | $51,259,000 | $59,693,000 | $35,067,000 |
| Non-Current Assets | |||||
| PPE Net | 18,393,000 | 18,940,000 | 16,274,000 | 14,882,000 | 13,745,000 |
| Investments And Advances | 2,227,000 | 15,368,000 | 15,069,000 | 21,526,000 | 20,262,000 |
| Intangibles | 123,938,000 | 132,683,000 | 94,745,000 | 74,354,000 | 77,893,000 |
| Other Non-Current Assets | 18,479,000 | 16,177,000 | 19,856,000 | 11,020,000 | 7,262,000 |
| TOTAL | $163,037,000 | $183,168,000 | $145,944,000 | $121,782,000 | $119,162,000 |
| Total Assets | $213,396,000 | $226,501,000 | $197,205,000 | $181,476,000 | $154,229,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,946,000 | 10,350,000 | 2,945,000 | 2,241,000 | 2,703,000 |
| Accounts payable and accrued liabilities | 5,633,000 | 6,710,000 | 6,809,000 | 5,578,000 | 4,283,000 |
| Accrued Expenses | 3,838,000 | 2,776,000 | 3,407,000 | 3,332,000 | 3,049,000 |
| Other current liabilities | 19,720,000 | 20,537,000 | 22,568,000 | 24,939,000 | 11,561,000 |
| TOTAL | $42,995,000 | $47,794,000 | $42,138,000 | $42,671,000 | $25,920,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,405,000 | 61,538,000 | 32,884,000 | 36,195,000 | 37,133,000 |
| Deferred Revenues | 1,511,000 | 2,700,000 | 2,520,000 | 3,067,000 | 1,113,000 |
| Other Non-Current Liabilities | 22,346,000 | 27,201,000 | 25,207,000 | 24,753,000 | 23,604,000 |
| TOTAL | $81,904,000 | $89,418,000 | $59,149,000 | $61,342,000 | $64,836,000 |
| Total Liabilities | $124,899,000 | $137,213,000 | $101,288,000 | $104,013,000 | $90,756,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,667,340 | 5,646,778 | 5,619,075 | 5,623,347 | 5,577,630 |
| Common Shares | 480,000 | 478,000 | 476,000 | 473,000 | 470,000 |
| Retained earnings | 116,725,000 | 118,353,000 | 125,656,000 | 103,394,000 | 90,392,000 |
| Other shareholders' equity | -7,548,000 | -7,687,000 | -8,049,000 | -5,635,000 | -5,075,000 |
| TOTAL | $88,497,000 | $89,288,000 | $95,916,000 | $77,462,000 | $63,473,000 |
| Total Liabilities And Equity | $213,396,000 | $226,501,000 | $197,204,000 | $181,475,000 | $154,229,000 |